Soft pastels ยท Free shipping over $75 ยท Shop the boutique
tirzepatide ban update

tirzepatide ban update ๐Ÿšจ Important on Compounded ๐Ÿšจ, As of March 19th, the FDA has officially banned compounded Tirzepatide formulations. We believe this is a huge disservice to patients seeking affordable FDA moves to remove GLP-1

SKU: 3149681650

4.3
USD29.90 USD59.90

Pay in 4 interest-free payments of $7.47 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours ยท Estimated delivery Aug 8 - Aug 13

Description

Highly recommend guys

tirzepatide ban update  Important on Compounded , As of March 19th, the FDA has officially banned compounded Tirzepatide formulations. We believe this is a huge disservice to patients seeking affordable FDA moves to remove GLP-1

Yesterday, it came out with a press release

tirzepatide ban update  Important on Compounded , As of March 19th, the FDA has officially banned compounded Tirzepatide formulations. We believe this is a huge disservice to patients seeking affordable FDA moves to remove GLP-1

Oct 6: People with a range of rheumatic diseases have a new treatment delivery option after the FDA approved an intravenous formulation of Novartis IL-17A antagonist Cosentyx (secukinumab)

tirzepatide ban update  Important on Compounded , As of March 19th, the FDA has officially banned compounded Tirzepatide formulations. We believe this is a huge disservice to patients seeking affordable FDA moves to remove GLP-1

Please avoid online compounded GLP-1 medications

tirzepatide ban update  Important on Compounded , As of March 19th, the FDA has officially banned compounded Tirzepatide formulations. We believe this is a huge disservice to patients seeking affordable FDA moves to remove GLP-1

Retatrutide trials lasted 48-68 weeks

tirzepatide ban update  Important on Compounded , As of March 19th, the FDA has officially banned compounded Tirzepatide formulations. We believe this is a huge disservice to patients seeking affordable FDA moves to remove GLP-1

The expiry date refers to the product correctly stored in an unopened package

tirzepatide ban update  Important on Compounded , As of March 19th, the FDA has officially banned compounded Tirzepatide formulations. We believe this is a huge disservice to patients seeking affordable FDA moves to remove GLP-1
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

Rebuild
Rebuild

US$ 21.12

4.1 (30 reviews)

Peptide BPC-157
Peptide BPC-157

US$ 28.26

4.4 (7 reviews)

BPC-157
BPC-157

US$ 29.44

4.4 (25 reviews)

recommand products